You call it a risk, why?
My point is that with the data we have you cannot conclude that patients progressed to class 3. More likely given comments made, controls did not progress. This would then mean that the treated population did not progress either .
Cell Therapy News/Articles, page-13671
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.10 |
Change
0.005(0.46%) |
Mkt cap ! $1.230B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.10 | $1.07 | $2.365M | 2.194M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 34 | 73362 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 92775 | 12 |
View Market Depth
| Last trade - 12.05pm 11/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |